Inventor · disambiguated record
Richard Marais
Also filed as: MARAIS RICHARD · MARAIS RICHARD MALCOL · MARAIS RICHARD MALCOLM
10 granted patents·3 pending applications·148 citations·filing 1994–2022
86Inventor score
Files withTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL6CANCER RES CAMPAIGN TECH4CANCER REC TECH LTD1CANCER RES INST ROYAL1
Top patents by PatentIndex Score
13 records- 0193US5728868AProdrugs of protein tyrosine kinase inhibitorsCANCER RES CAMPAIGN TECH·Filed 1994·Granted Mar 17, 1998·119 cites·3 claims
- 0288US10995088B2Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancerTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2020·Granted May 4, 2021·2 cites·22 claims
- 0386US7625922B2Imidazo[4,5-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-one compounds and analogs thereof as therapeutic compoundsCANCER REC TECH LTD·Filed 2005·Granted Dec 1, 2009·19 cites·44 claims
- 0480US10807974B2Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancerTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2017·Granted Oct 20, 2020·2 cites·35 claims
- 0573US11325915B2Lysyl oxidase inhibitorsTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2018·Granted May 10, 2022·1 cites·18 claims
- 0665US11608330B2Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancerTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2021·Granted Mar 21, 2023·0 cites·34 claims
- 0764US12060360B2Lysyl oxidase inhibitorsTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2022·Granted Aug 13, 2024·0 cites·16 claims
- 0864US2020216818A1Vaccinia virus for gene-directed enzyme prodrug therapyTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2019·Application pending·0 cites
- 0957US2016130564A1Vaccinia virus for gene-directed enzyme prodrug therapyCANCER RES INST ROYAL·Filed 2014·Application pending·0 cites
- 1044US6004550AIntracellular expression of carboxypeptidase G2 in a nitrogen mustard prodrug systemCANCER RES CAMPAIGN TECH·Filed 1995·Granted Dec 21, 1999·3 cites·10 claims
- 1141US2004014187A1Bacterial carboxypeptidase cpg2 variants and their use in gene directed enzyme prodrug therapyFiled 2001·Application pending·0 cites
- 1238US6025340ASurface expression of enzyme in gene directed prodrug therapyCANCER RES CAMPAIGN TECH·Filed 1995·Granted Feb 15, 2000·2 cites·23 claims
- 1329US5770731AImprovements relating to prodrugsCANCER RES CAMPAIGN TECH·Filed 1994·Granted Jun 23, 1998·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Richard Marais files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →